E-viri
PDF
Recenzirano
-
Akl, Elie A., MD, MPH, PhD; Welch, Vivian, PhD; Pottie, Kevin, MD; Eslava-Schmalbach, Javier, MD, MSc, PhD; Darzi, Andrea, MD, MPH; Sola, Ivan, BSc; Katikireddi, Srinivasa Vittal, MD; Singh, Jasvinder, MBBS, MPH; Murad, M. Hassan, MD, MPH; Meerpohl, Joerg, MD; Stanev, Roger, PhD; Lang, Eddy, MD; Matovinovic, Elizabeth, MD; Shea, Beverley, BScN, MSc, PhD; Agoritsas, Thomas, MD, PhD; Alexander, Paul E., PhD; Snellman, Alexandra, PhD; Brignardello-Petersen, Romina, DDS, MSc, PhD; Gloss, David, MD, MPH, TM; Thabane, Lehana, PhD; Shi, Chunhu, MSc, PhD; Stein, Airton T., PhD; Sharaf, Ravi, MD, MS; Briel, Matthias, PhD, MSc; Guyatt, Gordon, MD, MSc; Schünemann, Holger, MD, PhD, MSc, FRCP; Tugwell, Peter, MD, FRCPC
Journal of clinical epidemiology, 2017Journal Article
Abstract Objective to provide guidance for guideline developers on how to consider health equity at key stages of the guideline development process. Study Design and Setting literature review followed by group discussions and consensus building. Results The key stages at which guideline developers could consider equity include setting priorities, guideline group membership, identifying the target audience(s), generating the guideline questions, considering the importance of outcomes and interventions, deciding what evidence to include and searching for evidence, summarising the evidence and considering additional information, wording of recommendations, and evaluation and use. We provide examples of how guidelines have actually considered equity at each of these stages. Conclusion Guideline projects should consider the above suggestions for recommendations that are equity-sensitive.
